Summary: Revvity has launched an AI-powered optical character recognition solution designed to digitize handwritten test request forms, streamlining workflows and reducing manual data entry.

Takeaways:

  1. Revvity Transcribe AI automates the transcription of handwritten test request forms, improving workflow speed by 40% and reducing errors.
  2. The solution is especially beneficial for newborn screening labs, freeing up manual data entry resources for other critical tasks.
  3. The AI-supported OCR service integrates securely with laboratory information management systems, ensuring seamless data processing and validation.

Revvity announced the launch of Revvity Transcribe AI, an optical character recognition (OCR) service designed to convert handwritten text on test request forms into a digitized format. This solution is now available to clinical laboratories, aiming to streamline workflows and reduce manual data entry tasks.

Improving Test Request Form Processes

Revvity Transcribe AI addresses the need for laboratories to quickly and accurately process test request forms. In many laboratories, this is manual work that is time-consuming, prone to errors, and for which talent is hard to recruit, according to the company. Based on initial internal data, the solution improves overall data entry workflow speed by 40%, including data validation.

Support for Newborn Screening Labs

While beneficial for a range of applications, this service is especially valuable for newborn screening (NBS) laboratories and is compatible with the EVOYA platform, Revvity’s NBS software solution. Public screening labs process hundreds of handwritten dried blood spot (DBS) test cards every day, and by deploying Revvity Transcribe AI, the manual data entry resource can instead be made available for other tasks within the laboratory.

Further reading: Revvity Launches APOE Assay for Alzheimer’s Treatment Risk Assessment

“With the new Revvity Transcribe AI solution, labs can swiftly transcribe handwritten information on test request forms such as DBS filter paper cards using advanced AI-supported OCR technology,” says Norm Lord, vice president of digital products at Revvity. “This innovative service ensures that the digitized data is securely processed and seamlessly integrated into laboratory information management systems for review and verification. By automating this manually intensive process, Revvity Transcribe AI allows laboratory personnel to concentrate on other essential and time-sensitive tasks.”

Revvity Transcribe AI was introduced at the 2024 APHL Newborn Screening Symposium, Oct. 20-24, 2024, in Omaha, Nebraska.

Photo: Revvity